Adapthealth CORP 10-Q quarterly reports

AdaptHealth Corp. reported a 5.4% increase in net revenue for Q1 2026, reaching $819.8 million, but experienced a wider net loss of $16.0 million compared to the prior year.

AdaptHealth Corp. reported a 1.8% increase in Q3 2025 net revenue to $820.3 million, alongside significant debt reduction and an agreement in principle to settle a class action lawsuit.

AdaptHealth Corp. reported a decrease in net revenue and net income for Q2 2025, despite a significant gain from business dispositions, while grappling with persistent internal control weaknesses and multiple legal proceedings.

AdaptHealth Corp. reports a decrease in net revenue for Q1 2025, impacted by shifts in the diabetes segment and ongoing legal investigations, despite growth in the respiratory health segment.

AdaptHealth Corp. experienced a slight revenue increase in Q3 2024, offset by a goodwill impairment and ongoing legal settlements, impacting overall profitability.

AdaptHealth Corp. saw a slight revenue increase in Q2 2024, but faced challenges in its diabetes segment and incurred significant expenses related to legal settlements.

AdaptHealth Corp. saw a revenue increase in Q1 2024, but also experienced a net loss due to increased costs and a goodwill impairment.